USFDA completes inspection of Biocon drug substance unit at Bengaluru
No Observations
Banglore: Biotechnology major Biocon has said the inspection of its drug substance manufacturing site at Bengaluru campus by the US health regulator has concluded without any observations.
The week-long audit concluded without any observations and no Form 483 was issued, it added.
"The successful audit of this site reflects our strong commitment to cGMP compliance," the spokesperson said.
Earlier Medical Dialogues has reported that Biotechnology firm Biocon said it has received Establishment Inspection Report (EIR) from the US health regulator on the closure of inspection of its sterile drug product manufacturing facility in Bengaluru.
Read Also: Biocon receives EIR from USFDA for its Bengaluru facility producing sterile
Banglore: Biotechnology major Biocon has said the inspection of its drug substance manufacturing site at Bengaluru campus by the US health regulator has concluded without any observations.
"The United States Food and Drug Administration (USFDA) conducted a periodic current good manufacturing practice (cGMP) inspection of our drug substance manufacturing site at Bengaluru campus from Sep 17-21, 2018," Biocon spokesperson said in a statement.
The week-long audit concluded without any observations and no Form 483 was issued, it added.
"The successful audit of this site reflects our strong commitment to cGMP compliance," the spokesperson said.
Earlier Medical Dialogues has reported that Biotechnology firm Biocon said it has received Establishment Inspection Report (EIR) from the US health regulator on the closure of inspection of its sterile drug product manufacturing facility in Bengaluru.
Read Also: Biocon receives EIR from USFDA for its Bengaluru facility producing sterile
Biocon gets EU GMP certification for Bengaluru drug product facility
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd